www.helsinn.com Open in urlscan Pro
2606:4700:3036::ac43:8801  Public Scan

Form analysis
1 forms found in the DOM

/search-results/

<form class="header__form" action="/search-results/" data-no-results-url="https://www.helsinn.com/search-results/no-results-page/"><input name="searchTerm" class="header__input js-header-search-input" id="headerSearchInput" placeholder="Search here"
    autocomplete="off"> <button class="header__submit js-header-search-submit"> <span class="sr-only">Search Submit</span> </button></form>

Text Content

YOUR CHOICE REGARDING COOKIES ON THIS SITE

We use cookies to optimise site functionality and give you the best possible
experience.

AcceptDeclineCookie settings
Skip to content
 * News
 * Careers
 * Locations
 * Contact Us

Choose region
 * Global
 * United States

 * Report Adverse Event

 * About Us About Us
   back
   
   
   ABOUT US
   
   Helsinn is a global pharmaceutical company.
   
   Learn more
    * Mission, Vision and Values Mission, Vision and Values
    * Leadership Leadership
    * Our Story Our Story
    * Our Global Reach Our Global Reach

 * Products Products
   back
   
   
   PRODUCTS
   
   We provide products that improve the lives of patients with cancer and
   chronic diseases.
   
   Learn more
    * Akynzeo® Akynzeo®
    * Aloxi® Onicit® Paloxi® Aloxi® Onicit® Paloxi®
    * Arokaris® Arokaris®
    * Adlumiz® Adlumiz®
    * Valchlor®/Ledaga® Valchlor®/Ledaga®
    * Aulin® Mesulid® Nisulid® Aulin® Mesulid® Nisulid®

 * Business Business
   back
   
   
   BUSINESS
   
   Helsinn operates a unique integrated licensing business model.
   
   Learn more
    * Our Business Model Our Business Model
    * Business Development Business Development
      back to Business
       * In-Licensing
       * Partnering
   
    * Our Partnerships Our Partnerships

 * Technology Technology
   back
   
   
   TECHNOLOGY
   
   We have a comprehensive technical organization.
   
   Learn more
    * Manufacturing and Supply Manufacturing and Supply
    * Life-Cycle Development Life-Cycle Development
    * Research Grants Research Grants

 * ESG ESG
   back
   
   
   ESG
   
   We’re advancing ESG initiatives that contribute to our sustainable growth.
   
   Learn more
    * Sustainability Sustainability
    * Carbon Neutral Company Carbon Neutral Company
    * Ethics and Governance Ethics and Governance
      back to ESG
       * Codes of Conduct and Ethics
       * Reporting Channels
       * Compliance
       * Clinical Data Sharing Governance

 * Patients Patients
   back
   
   
   PATIENTS
   
   Our mission is to improve the lives of patients all over the world.
   
   Learn more
    * Commitment to Patients Commitment to Patients
    * Early Access Programs Early Access Programs
    * Educational Grants Educational Grants

Open Search Popup
Close Search Popup
Search Submit
Open/Close Navigation

Scroll to discover

Scroll to discover

Helsinn About us

We are a global pharmaceutical company and a leader in supportive care focused
on improving the health and quality of life of patients with cancer and chronic
diseases.

Learn more

We have always been driven by the desire to improve the lives of cancer
patients, guided by core values of integrity, passion and quality.

Learn more
Technology


A COMPREHENSIVE TECHNICAL ORGANIZATION

Our technical organization orchestrates a balanced mix of internal and external
capabilities, covering multiple aspect from development and regulatory affairs,
to manufacturing and supply chain.
Beyond routine production at our state-of-the-art manufacturing plant in
Ireland, we thrive in new product development starting from deep internal
know-how and extensive cross-functional collaborations, seamlessly transforming
strategic thoughts into real brands and evolutions thereof.


Learn more
Business


THE PARTNER OF CHOICE

We build, launch and commercialize solid brands globally with a strong focus in
supportive care, able to reach patients worldwide through our extensive
commercial and supply network, leveraging our integrated platform based on broad
technical expertise.

Learn more
ESG


COMMITTED TO RESPONSIBLE BUSINESS GROWTH

We believe building the trust of stakeholders through maximizing positive
societal impact will, in turn, make Helsinn more sustainable. Prioritizing the
well-being of patients and society creates a virtuous cycle, strengthening our
reputation, fostering collaboration, and driving innovation.

Open accordion


SUSTAINABILITY

Over the years, Helsinn has remained committed to running a responsible and
sustainable business by delivering high quality products to patients, whilst
reducing and improving our impact on the environment and society. Sustainability
has always been one of the main drivers in our corporate culture and has become
a crucial element of our strategic vision.

Learn more
Open accordion


CARBON NEUTRAL COMPANY

For the third year we have achieved carbon neutrality. We have progressed on our
path towards a reduction of our greenhouse gas footprint and the remaining
emissions have been offset through the purchase of Gold Standard certificates.

Learn more
Open accordion


ETHICS AND GOVERNANCE

We always strive to go further and bring better todays to even more and more
patients. Our ethical reputation are the key ingredients to deliver this
ambitious promise to patients and gain their trust. It is therefore vital that
we hold ourselves to the highest ethical standards across our entire business,
above and beyond what is required.

Learn more
News


READ OUR NEWS AND INSIGHTS

See All
Featured News
10/10/24


HELSINN ATTENDS EORTC ANNUAL MEETING 2024 WITH A FOCUS ON MYCOSIS FUNGOIDES
CUTANEOUS T-CELL LYMPHOMA (MF-CTCL)

Learn more
Featured News
10/10/24


HELSINN ATTENDS EORTC ANNUAL MEETING 2024 WITH A FOCUS ON MYCOSIS FUNGOIDES
CUTANEOUS T-CELL LYMPHOMA (MF-CTCL)

Learn more
Corporate 19/09/24

HELSINN GROUP APPOINTS RICCARDO CARBUCICCHIO TO THE BOARD OF DIRECTORS

Learn more
Life-cycle development 24/06/24

HELSINN GROUP ANNOUNCES AKYNZEO® (FOSNETUPITANT/PALONOSETRON) INJECTION IS NOW
AVAILABLE IN A READY-TO-USE VIAL IN THE US

Learn more
Partnership 12/06/24

HELSINN GROUP AND CHUGAI PHARMA EUROPE SIGN A PARTNERSHIP AGREEMENT RENEWAL TO
COMMERCIALIZE AKYNZEO® IN THE UK AND IRELAND

Learn more
Partnership 27/05/24

HELSINN AND ANGELINI PHARMA SIGN A PARTNERSHIP AGREEMENT RENEWAL TO
COMMERCIALIZE AULIN® AND MESULID® IN BULGARIA, CZECH REPUBLIC, HUNGARY, POLAND,
ROMANIA AND SLOVAK REPUBLIC

Learn more
See All
 * 
 * 
 * 

 * Products
 * Business
 * Technology
 * Patients

Helsinn Healthcare SA. All rights reserved. Helsinn Group 2024 ©
 * Privacy and Cookies Policy
 * Pharmacovigilance Data Privacy Policy
 * Terms of Use
 * Cookie Settings